股票名称 回购数 回购额 年累计回购数量(股) 年累计回购数量/总股本 蒙牛乳业(02319) 70.00 万 1014.14 万 1921.60 万 0.491% 云工场(N23027) 187.40 万 753.34 万 2451.70 万 5.330% 联易融科技-W(09959) 245.00 万 743.93 万 6543.90 万 3.063% 固生堂(02273) 23.20 万 683.52 万 467.81 万 1.974% 安东油田服务 (03337) 442.40 万 494.16 万 3369.20 万 1.140% 伟仕佳杰(00856) 50.00 万 453.30 万 663.80 万 0.462% 北森 控股(09669) 40.06 万 323.92 万 143.26 万 0.204% 中旭未来(09890) 22.82 万 313.05 万 598.58 万 1.120% 首 佳科技(00103) 280.00 万 221.20 万 5745.20 万 2.445% 美丽田园医疗健康(02373) 7.00 万 220.95 万 30.05 万 0.127% 康臣药业(01 ...

Core Viewpoint - The company, 心玮医疗-B (06609), has announced a share buyback of 3,000 shares at a total cost of HKD 166,100, with a buyback price of HKD 55.35 per share [1] Summary by Category - **Company Actions** - 心玮医疗-B has executed a buyback of 3,000 shares [1] - The total expenditure for the buyback amounts to HKD 166,100 [1] - The price per share for the buyback is set at HKD 55.35 [1]

Group 1 - The company, 心玮医疗-B (06609), announced a share buyback on October 20, 2025, spending HKD 166,100 to repurchase 3,000 shares at a price of HKD 55.35 per share [1]

格隆汇10月20日丨心玮医疗-B(06609.HK)公告，10月20日耗资16.6万港元回购3000股。 ...

翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 上海心瑋醫療科技股份有限公司 (於中華人民共和國註冊成立的有限責任公司) FF305 呈交日期： 2025年10月20日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 06609 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | 事件 | ...

Summary of Key Points Core Viewpoint - On October 17, 42 Hong Kong-listed companies conducted share buybacks, totaling 46.36 million shares and an aggregate amount of HKD 621 million [1][2]. Company-Specific Summaries - **Xiaomi Group-W**: - Repurchased 10.70 million shares for HKD 494 million, with a highest price of HKD 46.760 and a lowest price of HKD 45.900. The total buyback amount for the year reached HKD 1.537 billion [1][2]. - **Sihuan Pharmaceutical**: - Repurchased 15 million shares for HKD 21.76 million, with a highest price of HKD 1.470 and a lowest price of HKD 1.430. The total buyback amount for the year reached HKD 143.32 million [1][2]. - **Mengniu Dairy**: - Repurchased 1.20 million shares for HKD 16.97 million, with a highest price of HKD 14.250 and a lowest price of HKD 14.070. The total buyback amount for the year reached HKD 433.54 million [1][2]. - **AAC Technologies**: - Repurchased 300,000 shares for HKD 11.60 million, with a highest price of HKD 38.800 and a lowest price of HKD 38.480. The total buyback amount for the year reached HKD 84.64 million [1][2]. - **Vitasoy International**: - Repurchased 1.02 million shares for HKD 8.20 million, with a highest price of HKD 8.040 and a lowest price of HKD 8.020. The total buyback amount for the year reached HKD 27.54 million [1][2]. Overall Market Activity - The highest buyback amount on October 17 was from Xiaomi Group-W at HKD 494 million, followed by Sihuan Pharmaceutical at HKD 21.76 million. Other notable companies included Mengniu Dairy and AAC Technologies [1][2]. - In terms of share quantity, Sihuan Pharmaceutical led with 15 million shares repurchased, followed by Xiaomi Group-W with 10.70 million shares and Anton Oilfield Services with 4.49 million shares [1][2].

Core Viewpoint - Multiple companies in China conducted share buybacks on October 17, 2025, with Xiaomi Group-W leading in terms of buyback amount and quantity [1][2] Group 1: Buyback Details - Xiaomi Group-W (01810) repurchased 10.70 million shares for a total of 494 million yuan, with a year-to-date total of 27.30 million shares, representing 0.110% of its total share capital [2] - Four Seasons Pharmaceutical (00460) repurchased 15 million shares for 21.76 million yuan, with a year-to-date total of 59.60 million shares, representing 0.647% of its total share capital [2] - Mengniu Dairy (02319) repurchased 1.20 million shares for 16.97 million yuan, with a year-to-date total of 18.52 million shares, representing 0.473% of its total share capital [2] Group 2: Other Notable Buybacks - VITASOY International (00345) repurchased 1.02 million shares for 8.20 million yuan, with a year-to-date total of 566.60 million shares, representing 0.540% of its total share capital [2] - Zhongtong Express-W (02057) repurchased 445,000 shares for 8.41 million yuan, with a year-to-date total of 5.07 million shares, representing 0.630% of its total share capital [2] - Huazhong Media (00685) repurchased 500,000 shares for 50,000 yuan, with a year-to-date total of 225.60 million shares, representing 0.139% of its total share capital [2]

Group 1 - The company, Heartway Medical-B (06609), announced a share buyback plan [1] - The company will spend HKD 1.072 million to repurchase 19,500 shares [1]

格隆汇10月17日丨心玮医疗-B(06609.HK)发布公告，2025年10月17日耗资107.2万港元回购1.95万股，回 购价格每股54.1-55.65港元。 ...

Core Viewpoint - The company Xinwei Medical-B (06609) announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company will repurchase 19,500 shares at a total cost of HKD 1.072 million [1] - The buyback is scheduled for October 17, 2025, suggesting a strategic approach to managing its capital [1]